| Giant Cell Neoplasm studied in …STUDIED_INderived10 of 158show all (up to 200) |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 158 trials mapped (27 active) | — | — | Invasive Bladder Giant Cell Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832747Phase 2 · not yet recruiting A Study of DCC-3014 to Evaluate the Efficacy, Safety, and Pharmacokinetics in Subjects With TGCT · condition mapped ONTOLOGY_EXACT · 158 trials mapped (27 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667335Phase 1/Phase 2 · recruiting Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 158 trials mapped (27 active) | — | — | Invasive Bladder Giant Cell Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07499362Phase 2 · recruiting Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER) · condition mapped ONTOLOGY_EXACT · 158 trials mapped (27 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268385Phase 1 · active not recruiting Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas · condition mapped ONTOLOGY_EXACT · 158 trials mapped (27 active) | — | — | Adult Giant Cell Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05463796recruiting InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer · condition mapped ONTOLOGY_EXACT · 158 trials mapped (27 active) | — | — | Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ALIAS · 158 trials mapped (27 active) | — | — | Giant Cell Tumor of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07075471recruiting MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib · condition mapped ONTOLOGY_EXACT · 158 trials mapped (27 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07707882Phase 2 · not yet recruiting Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor · condition mapped ALIAS · 158 trials mapped (27 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04488822Phase 3 · active not recruiting A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT · condition mapped ONTOLOGY_EXACT · 158 trials mapped (27 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |